Australia markets closed

Alterity Therapeutics Limited (ATH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0060+0.0010 (+20.00%)
At close: 03:57PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
-
0
0
0
0
Operating expenses
Research development
-
13,199
14,746
12,284
10,098
Selling general and administrative
-
4,937
5,460
6,862
3,334
Total operating expenses
-
14,353
15,137
14,739
13,466
Operating income or loss
-
-14,353
-15,137
-14,739
-13,466
Total other income/expenses net
-
651.836
2,358
-591.337
-7.851
Income before tax
-
-13,702
-12,777
-15,309
-13,457
Income tax expense
-
104.459
70.008
0
0
Income from continuing operations
-
-13,807
-12,847
-15,309
-13,457
Net income
-
-13,807
-12,847
-15,309
-13,457
Net income available to common shareholders
-
-13,807
-12,847
-15,309
-13,457
Basic EPS
-
-0.01
-0.01
-0.01
-0.01
Diluted EPS
-
-0.01
-0.01
-0.01
-0.01
Basic average shares
2,439,898
2,427,842
2,405,990
1,696,876
894,872
Diluted average shares
2,439,898
2,427,842
2,405,990
1,696,876
894,872